BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 38716292)

  • 1. How Does Platelet-Rich Plasma Injection in Ovaries of Poor Responders Affect the Retrieved Oocytes, and Anti Mullerian Hormone: A Clinical Trial.
    Shahrokh Tehraninejad E; Razavi MO; Tarafdari Menshadi A; Shariat M; Shahsavari S; Haghollahi F; Azimi Nekoo E
    J Family Reprod Health; 2023 Sep; 17(3):165-173. PubMed ID: 38716292
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of intra-ovarian injection of autologous platelet-rich plasma in women with poor responders: a systematic review and meta-analysis.
    Vahabi Dastjerdi M; Sheibani S; Taheri M; Hezarcheshmeh FK; Jahangirian J; Jazayeri M; Hosseinirad H; Doohandeh T; Valizadeh R
    Arch Gynecol Obstet; 2024 Jun; 309(6):2323-2338. PubMed ID: 38589612
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The BISTIM study: a randomized controlled trial comparing dual ovarian stimulation (duostim) with two conventional ovarian stimulations in poor ovarian responders undergoing IVF.
    Massin N; Abdennebi I; Porcu-Buisson G; Chevalier N; Descat E; Piétin-Vialle C; Goro S; Brussieux M; Pinto M; Pasquier M; Bry-Gauillard H
    Hum Reprod; 2023 May; 38(5):927-937. PubMed ID: 36864699
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of intra-ovarian platelet rich plasma in women with poor ovarian response.
    Davari Tanha F; Salimi Setudeh S; Ebrahimi M; Feizabad E; Khalaj Sereshki Z; Akbari Asbagh F; Pakniat H; Khalili A; Kaveh Z; Saeedi S
    Caspian J Intern Med; 2023; 14(3):485-489. PubMed ID: 37520871
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of platelet-rich plasma in the treatment of infertility in poor responders in assisted human reproduction procedures.
    Pacu I; Zygouropoulos N; Dimitriu M; Rosu G; Ionescu CA
    Exp Ther Med; 2021 Dec; 22(6):1412. PubMed ID: 34676005
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of ovarian injection of autologous platelet rich plasma in patients with poor ovarian responder: a systematic review and meta-analysis.
    Li X; Liu H; Lin G; Xu L
    Front Endocrinol (Lausanne); 2023; 14():1292168. PubMed ID: 38155954
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of letrozole co-treatment during ovarian stimulation on oocyte yield, embryo development, and live birth rate in women with normal ovarian reserve: secondary outcomes from the RIOT trial.
    Bülow NS; Warzecha AK; Nielsen MV; Andersen CY; Holt MD; Petersen MR; Sopa N; Zedeler A; Englund AL; Pinborg A; Grøndahl ML; Skouby SO; Macklon NS
    Hum Reprod; 2023 Nov; 38(11):2154-2165. PubMed ID: 37699851
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The use of autologous platelet-rich plasma (PRP) versus no intervention in women with low ovarian reserve undergoing fertility treatment: a non-randomized interventional study.
    Melo P; Navarro C; Jones C; Coward K; Coleman L
    J Assist Reprod Genet; 2020 Apr; 37(4):855-863. PubMed ID: 32030554
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intraovarian Injection of Autologous Platelet-Rich Plasma Improves Therapeutic Approaches in The Patients with Poor Ovarian Response: A Before-After Study.
    Navali N; Sadeghi L; Farzadi L; Ghasemzadeh A; Hamdi K; Hakimi P; Niknafs B
    Int J Fertil Steril; 2022 Apr; 16(2):90-94. PubMed ID: 35639652
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preliminary report of intraovarian injections of autologous platelet-rich plasma (PRP) in extremely poor prognosis patients with only oocyte donation as alternative: a prospective cohort study.
    Barad DH; Albertini DF; Molinari E; Gleicher N
    Hum Reprod Open; 2022; 2022(3):hoac027. PubMed ID: 35795849
    [TBL] [Abstract][Full Text] [Related]  

  • 11. One Side Ovarian Rejuvenation: A Quasi-Experimental Study of the Effect of the Autologous Platelet Rich Plasma in Poor Ovarian Responders in IVF.
    Keikha F; Shahsavari S; Salari Y; Roozbeh N; Haghollahi F; Tarazjani MD; Razavi M; Shariat M; Bagheri M
    Ethiop J Health Sci; 2022 Nov; 32(6):1133-1140. PubMed ID: 36475267
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of Intraovarian Injection of Autologous Platelet-Rich Plasma on Ovarian Rejuvenation in Poor Responders and Women with Primary Ovarian Insufficiency.
    Aflatoonian A; Lotfi M; Saeed L; Tabibnejad N
    Reprod Sci; 2021 Jul; 28(7):2050-2059. PubMed ID: 33683669
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of intra-ovarian platelet-rich plasma administration on oocytes-dependent variables in patients with poor ovarian response: A retrospective study according to the POSEIDON criteria.
    Farimani M; Nazari A; Mohammadi S; Anvari Aliabad R
    Reprod Biol Endocrinol; 2021 Sep; 19(1):137. PubMed ID: 34496887
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diminished ovarian reserve and poor response to stimulation in patients <38 years old: a quantitative but not qualitative reduction in performance.
    Morin SJ; Patounakis G; Juneau CR; Neal SA; Scott RT; Seli E
    Hum Reprod; 2018 Aug; 33(8):1489-1498. PubMed ID: 30010882
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ovarian reserve parameters and IVF outcomes in 510 women with poor ovarian response (POR) treated with intraovarian injection of autologous platelet rich plasma (PRP).
    Cakiroglu Y; Yuceturk A; Karaosmanoglu O; Kopuk SY; Korun ZEU; Herlihy N; Scott RT; Tiras B; Seli E
    Aging (Albany NY); 2022 Mar; 14(6):2513-2523. PubMed ID: 35320118
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Individualised gonadotropin dose selection using markers of ovarian reserve for women undergoing in vitro fertilisation plus intracytoplasmic sperm injection (IVF/ICSI).
    Lensen SF; Wilkinson J; Leijdekkers JA; La Marca A; Mol BWJ; Marjoribanks J; Torrance H; Broekmans FJ
    Cochrane Database Syst Rev; 2018 Feb; 2(2):CD012693. PubMed ID: 29388198
    [TBL] [Abstract][Full Text] [Related]  

  • 17. AMH has no role in predicting oocyte quality in women with advanced age undergoing IVF/ICSI cycles.
    Dai X; Wang Y; Yang H; Gao T; Yu C; Cao F; Xia X; Wu J; Zhou X; Chen L
    Sci Rep; 2020 Nov; 10(1):19750. PubMed ID: 33184364
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does dual oocyte retrieval with continuous FSH administration increase the number of mature oocytes in low responders? An open-label randomized controlled trial.
    Boudry L; Mateizel I; Wouters K; Papaleo E; Mackens S; De Vos M; Racca A; Adriaenssens T; Tournaye H; Blockeel C
    Hum Reprod; 2024 Mar; 39(3):538-547. PubMed ID: 38199789
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of follitropin alfa/lutropin alfa in ART: a randomized controlled trial in poor ovarian responders.
    Humaidan P; Chin W; Rogoff D; D'Hooghe T; Longobardi S; Hubbard J; Schertz J;
    Hum Reprod; 2017 Mar; 32(3):544-555. PubMed ID: 28137754
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cumulative delivery rate per aspiration IVF/ICSI cycle in POSEIDON patients: a real-world evidence study of 9073 patients.
    Esteves SC; Yarali H; Vuong LN; Carvalho JF; Özbek İY; Polat M; Le HL; Pham TD; Ho TM; Humaidan P; Alviggi C
    Hum Reprod; 2021 Jul; 36(8):2157-2169. PubMed ID: 34179973
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.